TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Human Vaccine Adjuvants Market - Key Market Dynamics

4.1 Middle East & Africa Human Vaccine Adjuvants Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Rising Prevalence of Chronic Diseases

4.2.2 Growing Focus on Immunization Programs

4.3 Market Restraints

4.3.1 Manufacturing Complexities and Regulatory Challenges

4.4 Market Opportunities

4.4.1 Growing Pharmaceutical Industry

4.5 Future Trends

4.5.1 Rising Trend of Personalized Vaccines

4.6 Impact of Drivers and Restraints:

5. Human Vaccine Adjuvants Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Human Vaccine Adjuvants Market Revenue (US$ Million), 2020 - 2030

5.2 Middle East & Africa Human Vaccine Adjuvants Market Forecast Analysis

6. Middle East & Africa Human Vaccine Adjuvants Market Analysis - by Type

6.1 Particulate Adjuvant

6.1.1 Overview

6.1.2 Particulate Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Emulsion Adjuvant

6.2.1 Overview

6.2.2 Emulsion Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Combination Adjuvant

6.3.1 Overview

6.3.2 Combination Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Human Vaccine Adjuvants Market Analysis - by Application

7.1 Influenza

7.1.1 Overview

7.1.2 Influenza: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Hepatitis

7.2.1 Overview

7.2.2 Hepatitis: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Human papilloma virus (HPV)

7.3.1 Overview

7.3.2 Human Papilloma Virus (HPV): Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Human Vaccine Adjuvants Market Analysis - by End User

8.1 Pharmaceutical and Biotechnology Companies

8.1.1 Overview

8.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.2 CMOs and CROs

8.2.1 Overview

8.2.2 CMOs and CROs: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Human Vaccine Adjuvants Market - Country Analysis

9.1 Middle East & Africa

9.1.1 Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

9.1.1.1 Saudi Arabia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 Saudi Arabia Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.1.2 Saudi Arabia Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.1.3 Saudi Arabia Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.2 South Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 South Africa Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.2.2 South Africa Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.2.3 South Africa Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.3 United Arab Emirates Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 United Arab Emirates Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.3.2 United Arab Emirates Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.3.3 United Arab Emirates Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.4 Rest of Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.4.1 Rest of Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.4.2 Rest of Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.4.3 Rest of Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by End User

10. Industry Landscape

10.1 Overview

11. Company Profiles

11.1 Novartis AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 CSL Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Seppic SA

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Croda International Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Novavax Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Phibro Animal Health Corp

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Human Vaccine Adjuvants Market Segmentation

Table 2. Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 4. Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 5. Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by End User

Table 6. Saudi Arabia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 7. Saudi Arabia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 8. Saudi Arabia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. South Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. South Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 11. South Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. United Arab Emirates Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 13. United Arab Emirates Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 14. United Arab Emirates Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Rest of Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 16. Rest of Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 17. Rest of Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 18. Recent Growth Strategies in the Human Vaccine Adjuvants Market

Table 19. Glossary of Terms, Human Vaccine Adjuvants Market

List of Figures

Figure 1. Middle East & Africa Human Vaccine Adjuvants Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Middle East & Africa Human Vaccine Adjuvants Market Revenue (US$ Million), 2022 - 2030

Figure 4. Middle East & Africa Human Vaccine Adjuvants Market Share (%) - by Type (2022 and 2030)

Figure 5. Particulate Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Emulsion Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Combination Adjuvant: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Middle East & Africa Human Vaccine Adjuvants Market Share (%) - by Application (2022 and 2030)

Figure 10. Influenza: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Hepatitis: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Human papilloma virus (HPV): Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Middle East & Africa Human Vaccine Adjuvants Market Share (%) - by End User (2022 and 2030)

Figure 15. Pharmaceutical and Biotechnology Companies: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. CMOs and CROs: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)

Figure 19. Middle East & Africa Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 20. Saudi Arabia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 21. South Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 22. United Arab Emirates Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 23. Rest of Middle East & Africa Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)